Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder

Journal of Trauma and Dissociation

Volumn 17, Issue 4, 2016, Pages 494-510

  George, Kirsten C ^a   Kebejian, Lisa ^a   Ruth, Leigh J ^a   Miller, Christopher W T ^a   Himelhoch, Seth ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Nightmares; posttraumatic stress disorder; prazosin; sleep disturbance

Indexed keywords

PLACEBO; PRAZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;

DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPOTENSION; MEDLINE; META ANALYSIS; NIGHTMARE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCINFO; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP QUALITY; SYSTOLIC BLOOD PRESSURE; ADULT; DREAM; DRUG EFFECTS; SLEEP DISORDER;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADULT; DREAMS; HUMANS; PRAZOSIN; SLEEP WAKE DISORDERS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84969651081     PISSN: 15299732     EISSN: 15299740     Source Type: Journal    
DOI: 10.1080/15299732.2016.1141150     Document Type: Review

References (22)

1. M.Ahmadpanah,, P.Sabzeiee,, S.M.Hosseini,, S.M.Hosseini,, S.Torabian,, M.Haghighi,, … S.Brand, (2014). Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology, 69(4), 235–242. doi:10.1159/000362243
2. W.Berger,, M.V.Mendlowicz,, C.Marques-Portella,, G.Kinrys,, L.F.Fontenelle,, C.R.Marmar,, & I.Figueira, (2009). Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33(2), 169–180. doi:10.1016/j.pnpbp.2008.12.004
3. N.C.Bernardy,, B.C.Lund,, B.Alexander,, A.B.Jenkyn,, P.P.Schnurr,, & M.J.Friedman, (2013). Gender differences in prescribing among veterans diagnosed with posttraumatic stress disorder. Journal of General Internal Medicine, 28(Suppl. S2), S542–S548. doi:10.1007/s11606-012-2260-9
4. D.De Berardis,, S.Marini,, N.Serroni,, F.Iasevoli,, C.Tomasetti,, A.Bartolomeis,, … M.D.Giannantonio, (2015). Targeting the noradrenergic system in posttraumatic stress disorder: A systematic review and meta-analysis of prazosin trials. Current Drug Targets, 16(10), 1094–1106. doi:10.2174/1389450116666150506114108
5. A.Germain,, R.Richardson,, D.E.Moul,, O.Mammen,, G.Haas,, S.D.Forman,, … E.A.Nofzinger, (2012). Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US military veterans. Journal of Psychosomatic Research, 72(2), 89–96. doi:10.1016/j.jpsychores.2011.11.010
6. J.L.Gradus, (2015). Epidemiology of PTSD. Retrieved from http://www.ptsd.va.gov/professional/PTSD-overview/epidemiological-facts-ptsd.asp
7. R.M.Graham,, I.R.Thornell,, J.M.Gain,, C.Bagnoli,, H.F.Oates,, & G.S.Stokes, (1976). Prazosin: The first-dose phenomenon. British Medical Journal, 2(6047), 1293–1294. doi:10.1136/bmj.2.6047.1293
8. B.Green, (2014). Prazosin in the treatment of PTSD. Journal of Psychiatric Practice, 20(4), 253–259. doi:10.1097/01.pra.0000452561.98286.1e
9. M.M.Koola,, P.Sajoy,, V.Fawcett,, & J.A.Fawcett, (2014). High-dose prazosin for the treatment of post-traumatic stress disorder. Therapeutic Advances in Psychopharmacology, 4(1), 43–47. doi:10.1177/2045125313500982
10. M.J.Maher,, S.A.Rego,, & G.M.Asnis, (2006). Sleep disturbances in patients with post-traumatic stress disorder: Epidemiology, impact and approaches to management. CNS Drugs, 20(7), 567–590. doi:10.2165/00023210-200620070-00003
11. T.A.Mellman,, R.E.Clark,, & W.J.Peacock, (2003). Prescribing patterns for patients with posttraumatic stress disorder. Psychiatric Services, 54(12), 1618–1621. doi:10.1176/appi.ps.54.12.1618
12. M.A.Raskind,, E.R.Peskind,, D.J.Hoff,, K.L.Hart,, H.A.Holmes,, D.Warren,, … M.E.McFall, (2007). A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biological Psychiatry, 61(8), 928–934. doi:10.1016/j.biopsych.2006.06.032
13. M.A.Raskind,, E.R.Peskind,, E.D.Kanter,, E.C.Petrie,, A.Radant,, C.E.Thompson,, … M.M.McFall, (2003). Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: A placebo-controlled study. American Journal of Psychiatry, 160(2), 371–373. doi:10.1176/appi.ajp.160.2.371
14. M.A.Raskind,, K.Peterson,, T.Williams,, D.J.Hoff,, K.Hart,, H.Holmes,, … E.R.Peskind, (2013). A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. American Journal of Psychiatry, 170(9), 1003–1010. doi:10.1176/appi.ajp.2013.12081133
15. J.Sareen, (2014). Posttraumatic stress disorder in adults: Impact, comorbidity, risk factors, and treatment. Canadian Journal of Psychiatry/Revue Canadienne De Psychiatrie, 59(9), 460–467.
16. G.Seda,, M.M.Sanchez-Ortuno,, C.H.Welsh,, A.C.Halbower,, & J.D.Edinger, (2015). Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmare frequency, sleep quality, and posttraumatic stress. Journal of Clinical Sleep Medicine, 11(1), 11–22.
17. N.Sjostrom,, J.Hetta,, & M.Waern, (2009). Persistent nightmares are associated with repeat suicide attempt: A prospective study. Psychiatry Research, 170(2–3), 208–211. doi:10.1016/j.psychres.2008.09.006
18. V.I.Spoormaker,, A.Sturm,, K.C.Andrade,, M.S.Schroter,, A.Sturm,, R.Goya-Maldonado,, … M.Czisch, (2010). The neural correlates and temporal sequence of the relationship between shock exposure, disturbed sleep and impaired consolidation of fear extinction. Journal of Psychiatric Research, 44(16), 1121–1128. doi:10.1016/j.jpsychires.2010.04.017
19. F.B.Taylor,, P.Martin,, C.Thompson,, J.Williams,, T.A.Mellman,, C.Gross,, … M.A.Raskind, (2008). Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: A placebo-controlled study. Biological Psychiatry, 63(6), 629–632. doi:10.1016/j.biopsych.2007.07.001
20. F.B.Taylor,, & M.A.Raskind, (2002). The alpha-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 22(1), 82–85. doi:10.1097/00004714-200202000-00013
21. T.Tsujii, (2000). Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: A short-term open, randomized multicenter study. International Journal of Urology, 7(6), 199–205. doi:10.1046/j.1442-2042.2000.00175.x
22. B.W.Writer,, E.G.Meyer,, & J.E.Schillerstrom, (2014). Prazosin for military combat-related PTSD nightmares: A critical review. Journal of Neuropsychiatry and Clinical Neurosciences, 26(1), 24–33. doi:10.1176/appi.neuropsych.13010006